Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy is a research paper published in Molecular Therapy — Nucleic Acids (2023). On theSindex it has a DataRank of 0. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: R01 GM119186
NIAMS NIH HHS
Grant: R21 AR081018
National Institutes of Health
Grant: 5R01GM119186-04
Mechanism of high-efficiency transduction of hepatocytes by optimized AAV vectors
National Institutes of Health
Grant: 1R21AR081018-01A1
Development of optimized AAVrh74 vectors for gene therapy of muscular dystrophies
FWCI
15.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Additional file 1 of Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice
Additional file 1 of Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice
Additional file 1 of The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues
Additional file 1 of The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues